Skip to main content

Table 3 Toxicity to chemoradiation by CTCAE v.4.0

From: Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer

 

All grades

Grade 3

Grade 4

 

No.

%

No.

%

No.

%

Neutropenia

82

92.1

37

41.6

15

16.9

Febrile neutropenia

5

5.6

0

Leukopenia

83

93.3

46

51.7

11

12.4

Thrombocytopenia

78

87.6

18

20.2

6

6.7

Anemia

88

98.9

15

16.9

9

10.1

Nausea

25

28.1

0

0

Emesis

8

9.0

0

0

Diarrhea

18

20.2

1

1.1

0

Mucositis

64

71.9

3

3.4

0

Alopecia

0

0

0

Skin

30

33.7

0

0

Neuropathy

9

10.1

0

0

Fatigue

68

76.4

3

3.4

0

Liver

51

57.3

1

1.1

0

Cardiac toxicity

1

1.1

0

0

Pulmonary embolism

0

0

0

Kidney

25

28.1

3

3.4

0

Infection

44

49.4

11

12.4

0

  1. CTCAE = common toxicity criteria